What happened
A 2026 paper in Frontiers in Global Women’s Health proposes a strategic framework for aligning femtech innovation with equitable real-world impact. It identifies structural, regulatory, data and access barriers that can limit benefits.
Why it matters
A women’s-health product can grow while the health gap stays the same. Equity has to be tested through price, language, evidence populations, disability access and the path from insight to care.
What to watch
Whether companies publish subgroup performance, build for low-resource contexts and measure outcomes beyond acquisition and engagement.
